Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This is a monocentric retro-prospective observational study that will be conducted on all COVID19 positive patients hospitalized at the S. Gerardo Hospital in Monza.
Description: Identify risk factors for intra-hospital mortality in patients admitted to the COVID + hospital wards of San Gerardo hospital.
Measure: Identify risk factors for intra-hospital mortality. Time: Until patient discharge from the hospital (approximately 1 year)Description: Identify the risk factors to build a prognostic score through which it is possible to define a stratification that immediately guides the therapeutic choices.
Measure: Identify risk factors to build a prognostic score. Time: Until patient discharge from the hospital (approximately 1 year)Description: Identify the risk factors to build a prognostic score through which it is possible to define a stratification that immediately directs towards the right intensity of care.
Measure: Identify risk factors to build a prognostic score. Time: Until patient discharge from the hospital (approximately 1 year)Description: Description of the predictive factors for the hospitalization duration.
Measure: Predictive factors for the hospitalization duration. Time: Until patient discharge from the hospital (approximately 1 year)Description: Description of the predictive factors for the clinical status of patients based on "Ordinal Scale for Clinical Improvement" defined by OMS (
Measure: Predictive factors for clinical status patients based on "Ordinal Scale for Clinical Improvement" Time: Until patient discharge from the hospital (approximately 1 year)Description: Description of efficacy of the anti-viral therapies used today without particular restrictions, but on which solid clinical functioning tests are lacking.
Measure: Describe the anti-viral therapies used commonly in this emergency in terms of efficacy Time: Until patient discharge from the hospital (approximately 1 year).Description: Description of safety of the anti-viral therapies used today without particular restrictions, but on which solid clinical functioning tests are lacking.
Measure: Describe the anti-viral therapies used commonly used in this emergency in terms of safety Time: Until patient discharge from the hospital (approximately 1 year).Description: Description of the disease clinical course in patients 12 months after discharge (mortality, neurological, respiratory and cardiac outcomes).
Measure: Monitor the clinical course of the disease in discharged patients. Time: 12 month after dischargeAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports